VEGF-C and its receptor VEGFR-3 are mediators of lymphangiogenesis [7], and higher expression in metastatic lesions compared to primary tumours reveals the possible role of lymphangiogenesis in metastatic tumour spread. The gene discussed is FLT4; the disease is neoplasm.